Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of a Targeted Brief Intervention for Recent Suicide Attempt Survivors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03894462
Recruitment Status : Not yet recruiting
First Posted : March 28, 2019
Last Update Posted : September 6, 2019
Sponsor:
Collaborators:
Northwestern University
Hutchings Psychiatric Center
Information provided by (Responsible Party):
Anthony Pisani, University of Rochester

Brief Summary:
Effective, brief, low-cost interventions for individuals who attempt suicide are needed to save lives and achieve the goals of the National Strategy for Suicide Prevention. In response to an NIMH Notice of Interest, this time-sensitive proposal leverages an existing federal investment in Zero Suicide to test the effectiveness of a highly promising new treatment for recent suicide attempt survivors and learn how it works. If hypotheses are supported, the study will provide evidence of a brief, practical, and cost-effective therapy that reduces suicide reattempts in a real-world health setting.

Condition or disease Intervention/treatment Phase
Suicide, Attempted Behavioral: Attempted Suicide Short Intervention Program Behavioral: Zero Suicide Usual Care Not Applicable

Detailed Description:

Suicide rates are rising in the US and more than a million Americans try to take their own lives each year. Effective, brief, low-cost interventions for individuals who attempt suicide are essential to saving lives and achieving the goals of the National Strategy for Suicide Prevention. This study takes advantage of a time-sensitive research opportunity to test the effectiveness of the Attempted Suicide Short Intervention Program (ASSIP), a manualized 3-session intervention for recent suicide attempt survivors that produced dramatic reductions in suicide attempts in a efficacy trial-80% fewer reattempts and an average of 72% fewer hospital days over 24 months in the intervention group compared to controls. This research will now test its effectiveness of in the US public mental health care system, examine theoretically grounded mechanisms, and explore cost-effectiveness. ASSIP is currently being implemented by New York State in a Zero Suicide initiative funded by SAMHSA. Consistent with NIMH Notice of Interest MH-17-03, this project leverages this federal investment and a strong state partnership to conduct effectiveness research.

Effectiveness. The primary aim of this study is to determine the effectiveness of ASSIP in reducing suicide reattempts in a community mental health setting in the U.S. To accomplish this aim the investigators will conduct a randomized controlled trial with 400 individuals referred from psychiatric inpatient and emergency services following a suicide attempt. Participants will be randomized to receive either usual care + ASSIP (intervention arm) or usual care only (control arm), and followed for assessments at baseline, 3, 6, 12, and 18 months.

Mechanism. The secondary aim of this study to examine the psychological mechanisms of ASSIP, as predicted by the Interpersonal Theory of Suicide. To accomplish this aim the investigators will conduct statistical analyses of a mediation model to determine (a) whether ASSIP improves perceptions of low belonging and being a burden on others, and (b) whether the effect of treatment on reductions in suicide re-attempts is mediated by these improvements.

Cost-Effectiveness. The exploratory aim of this study is to estimate, from the perspective of an ASSIP provider, the incremental cost per suicide attempt averted by delivering ASSIP to supplement usual care following a suicide attempt. To accomplish this aim the investigators gather pre-implementation accounting data, personnel time logs, and 12-month medical record reports of emergency and inpatient psychiatric visits. The investigators will use these data together with effectiveness results to calculate the incremental cost-effectiveness ratio (ICER). This time-sensitive study builds effectiveness research into a federally-funded Zero Suicide grant to New York state, consistent with a specific request from NIMH for such applications. If hypotheses are supported, the study will provide evidence of a brief, practical, and novel therapy that reduces suicide reattempts in a real-world health setting.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 400 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Randomized controlled trial
Masking: Single (Care Provider)
Masking Description: Providers giving usual care will not know if participants are also receiving ASSIP intervention.
Primary Purpose: Prevention
Official Title: Effectiveness of a Targeted Brief Intervention for Recent Suicide Attempt Survivors
Estimated Study Start Date : October 1, 2019
Estimated Primary Completion Date : January 2023
Estimated Study Completion Date : January 2024

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Suicide

Arm Intervention/treatment
Active Comparator: Zero Suicide Usual Care
In Onondaga County, NYS aims to implement a countywide "Zero Suicide Safety Net" of providers who share enhanced protocols for clinical care, staff training, and data collection (improved EMR coding of suicidal behavior). Participating behavioral health systems have agreed to common protocols for clinical care, training, and data collection. Participating providers receive robust training in suicide prevention best practices. Because of the wide participation of mental health facilities in the NYS-OMH Zero Suicide project, most subjects who engage in outpatient treatment will receive that treatment in facilities that are adopting NYS Zero Suicide protocols. Those who do not engage in care will nonetheless experience enhanced transition and follow-up contact from the services from which they are discharged.
Behavioral: Zero Suicide Usual Care
Participants will have access to outpatient treatment in facilities that are adopting NYS Zero Suicide protocols. Those who do not engage in care will nonetheless experience enhanced transition and follow-up contact from the services from which they are discharged

Experimental: Zero Suicide Usual Care + ASSIP

Patients in this treatment arm will receive ASSIP brief therapy in addition to being able to access any usual care as recommended by their provider.

ASSIP is a manualized, three-session intervention: In Session 1, the therapist guides the patient in telling the story of their attempt. The session is video recorded. In Session 2, the therapist and patient sit side-by-side to view selections of the video, working together to understand the feelings and events that preceded the attempt. The patient is assigned a homework task. In Session 3, the therapist and patient create a summary of the suicide attempt and what led up to it, along with creating a personal safety plan.

Behavioral: Attempted Suicide Short Intervention Program
ASSIP is a manualized, three-session intervention: In Session 1, the therapist guides the patient in telling the story of their attempt. The session is video recorded. In Session 2, the therapist and patient sit side-by-side to view selections of the video, working together to understand the feelings and events that preceded the attempt. The patient is assigned a homework task. In Session 3, the therapist and patient create a summary of the suicide attempt and what led up to it, along with creating a personal safety plan.




Primary Outcome Measures :
  1. Time to Suicide Attempt [ Time Frame: Up to 18 months ]
    Time from randomization to first suicide re-attempt



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Suicide attempt within past 60 days, with attempt defined as acknowledgement of some intent to die using a standard item
  • Ability and willingness to provide information and permission to contact two persons in case of emergency or inability to reach the participant for follow-up.

Exclusion Criteria:

  • Inability to communicate with the researcher in English.
  • Acute psychiatric instability (e.g., psychotic symptoms).
  • Residence outside of Onondaga County (NYS-OMH Zero Suicide program and protocols will only be offered to providers in this county).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03894462


Contacts
Layout table for location contacts
Contact: Anthony R Pisani, PhD 585-275-3644 anthony_pisani@urmc.rochester.edu

Locations
Layout table for location information
United States, New York
Hutchings Psychiatric Center Not yet recruiting
Syracuse, New York, United States, 13210
Contact: Seetha Ramanathan, MD         
Sponsors and Collaborators
University of Rochester
Northwestern University
Hutchings Psychiatric Center

Publications:
Layout table for additonal information
Responsible Party: Anthony Pisani, Principal Investigator, University of Rochester
ClinicalTrials.gov Identifier: NCT03894462     History of Changes
Other Study ID Numbers: 3353
First Posted: March 28, 2019    Key Record Dates
Last Update Posted: September 6, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Anthony Pisani, University of Rochester:
Zero Suicide
Effectiveness
Brief Treatment
Interpersonal Theory
Cost-Effectiveness
Additional relevant MeSH terms:
Layout table for MeSH terms
Suicide
Suicide, Attempted
Self-Injurious Behavior
Behavioral Symptoms